ONCSM vs ULUSE Comparison
Price, market cap, valuation, profitability and leverage metrics of ONCSM and ULUSE side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | ONCSM | ULUSE | Sector median |
|---|---|---|---|
| Last price (TL) | 83.40 | 159.90 | 18.72 |
| Daily change | −6.40% | −4.93% | −4.53% |
| Market cap | TRY 2B | TRY 12.8B | TRY 4.4B |
| P/E | 26.70 | 16.87 | 18.20 |
| P/B | 4.21 | 13.68 | 1.14 |
| Dividend yield | — | 2.96% | 0.90% |
| Return on equity | 18.26% | 138.25% | 1.78% |
| Free float | 40.86% | 6.31% | 37.21% |
Popular comparisons
Related pages
About the ONCSM vs ULUSE comparison
Price, market cap, valuation multiples, profitability and leverage of ONCSM (Oncosem Onkolojik Sistemler) and ULUSE (Ulusoy Elektrik) side by side as of Sep 28, 2026, 11:41. Of the 16 metrics compared, ONCSM leads in 10 and ULUSE leads in 6.
Highlights: Daily change: ULUSE leads (−4.93% vs −6.40%). Market cap: ULUSE leads (TRY 12.8B vs TRY 2B). P/E: ULUSE leads (16.87 vs 26.70). P/B: ONCSM leads (4.21 vs 13.68). EV/EBITDA: ONCSM leads (7.50 vs 41.60). EV/Sales: ULUSE leads (2.29 vs 4.76). Gross margin: ONCSM leads (54.30% vs 12.70%). EBITDA margin (annual): ONCSM leads (41.91% vs 4.20%).
Frequently asked questions
Is ONCSM or ULUSE cheaper?
By P/E, ULUSE is cheaper (26.70 vs 16.87); by P/B, ONCSM trades at the lower multiple (4.21 vs 13.68).
Which is more profitable, ONCSM or ULUSE?
Annual net margin is 10.83% for ONCSM and 7.51% for ULUSE; return on equity is 18.26% for ONCSM and 138.25% for ULUSE.
Which is more leveraged, ONCSM or ULUSE?
The leverage ratio is 44.59 for ONCSM and 87.80 for ULUSE; net debt/EBITDA is 0.48 for ONCSM and 3.38 for ULUSE. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.